INVU

Under INVU's existing technology umbrella, we are capable of addressing several patient use cases:

Standard Home Non-Stress Tests

Pregnancy indications include:

• Mild high-risk
• Hypertension
• IUGR
• Diabetes
• Advanced maternal age
• High-BMI

Expected Provider Benefits:

• Increased throughput
• Reduced burnout
• Improved billing
• Reduced staff burden

Rural Low- and High-Risk Pregnancies

Pregnancy indications include:

• Poor care access
• Socioeconomic limits

Expected Provider Benefits:

• Increased throughput
• Reduced staff burden

OB-ED Triage

Pregnancy indications include:

• Low-risk
• Mild high-risk
• DFM or anxious mom

Expected Provider Benefits:

• Provider efficiency
• Reduced staff burden
• Reduced hospitalization
• Improved capacity

De-Hospitalization

Pregnancy indications include:

• Moderate high-risk (PPROM, preeclampsia, GDM, etc.)

Expected Provider Benefits:

• Reduced staff burden
• Improve patient outcomes
• Reduce hospitalization
• Improved capacity

Our platform has strong implications for how high-risk pregnancies are managed, especially during the current COVID-19 pandemic. INVU allows for a complete shift of care away from a clinical setting for routine pregnancy monitoring, which means that both COVID-19 positive patients who need to be kept isolated, as well as high-risk patients who need to be safeguarded, are able to mitigate infection. Our platform can also significantly reduce staff burden, which is becoming a growing problem compounded by the Great Resignation.

NA at this time.

INVU stands head and shoulders above other remote pregnancy monitoring solutions for a number of reasons. We like to think of these through three distinct lenses as: Deep Data, Early Use, Accessed Anywhere.

Deep Data

• INVU's proprietary sensor band and accompanying cloud algorithms allow us to gain unprecedented insight in to the womb. Our collection of maternal and fetal data is achieved through a dual-modality of both ECG (biopotential) and PCG (sound) signals, all collected passively. This is unique in the field of pregnancy monitoring, and allows us to collect more reliable and robust signals than the standard of care today. Most of our competitors, on the other hand, utilize either unreliable and outdated legacy technologies such as doppler and toco, or EHG to obtain data.

Early Use

• INVU is FDA approved for antepartum use from gestational age 32 and onwards, with future FDA approvals intended to push this even earlier. By reaching patients in their third trimester, rather than when they reach the labor and delivery room, we enable greater insight into their health and trends. Our platform is designed to help doctors be proactive, rather than reactive.

Accessed Anywhere

• With the patient bearing the brunt of the care burden, especially when undergoing high-risk management, INVU was designed to be accessed by anyone, anywhere. As long as there is reliable internet access and a smartphone handy, the patient can undergo their monitoring session in comfort and with peace of mind. This significantly breaks down barriers of access to care, especially for underprivileged and rural patients.